NASDAQ · Financial Statements
Blue Water Vaccines, Inc. (BWV) Financial Statements
$0.18
NASDAQ: BWV
Market Cap $3.41M
Overview Financials Dividend Blue Water Vaccines, Inc. most recently reported annual revenue of $1.0M, a net loss of $14.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2024 2025 Revenue $0 $0 $0 $3.0M $1.0M Operating Profit $-2.0M $-3.0M $-13.0M $-56.0M $-18.0M Net Profit $-2.0M $-3.0M $-13.0M $-59.0M $-14.0M EPS $-0.14 $-0.31 $-1.08 $-21.45 $-16.56 Op Margin — — — -2238.0% -2190.0%
Balance Sheet (USD)
Metric 2020 2021 2022 2024 2025 Total Assets $5.0M $3.0M $26.0M $28.0M $25.0M Total Liabilities $0 $2.0M $4.0M $19.0M $9.0M Cash $4.0M $2.0M $26.0M $1.0M $5.0M Borrowings $0 $0 $0 $9.0M $0
Cash Flow (USD)
Metric 2020 2021 2022 2024 2025 Operating Cash Flow $-2.0M $-2.0M $-9.0M $-10.0M $-10.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $32.0M $8.0M $15.0M Net Cash Flow $-2.0M $-2.0M $24.0M $-4.0M $5.0M Free Cash Flow $-2.0M $-2.0M $-9.0M $-11.0M $-10.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.34 FCF Yield -3523.40% Quick Ratio 1.37 Interest Coverage -12.81 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .